Resolution of dupilumab-associated alopecia areata with dosage modification

• Maansi Kulkarni, BS,
• Craig A. Rohan, MD,
• David Morris, MD,
• Jeffrey B. Travers, MD, PhD

Affiliations

Maansi Kulkarni, BS

Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio

Craig A. Rohan, MD

Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Dayton VA Medical Center, Dayton, Ohio

David Morris, MD

Department of Pediatrics, Boonshoft School of Medicine, Wright State University, Dayton, Ohio

Jeffrey B. Travers, MD, PhD

Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Department of Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio; Dayton VA Medical Center, Dayton, Ohio; Correspondence to: Jeffrey B. Travers, MD, PhD, Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, 3640 Colonel Glenn Hwy, Dayton, OH 45436.